Facio raises €2 million


Leiden, the Netherlands - November 6, 2014

Facio Therapies has secured €2 million (about US$ 2.5 million) in initial financing from founding investors Kees van der Graaf and Bill Moss AM. Facio will use these funds towards its drug development program, which is aimed at stopping the progression of FSHD. In people with FSHD, the activity of the protein, SMCHD1, is too low…. read more

Facio attends 2014 FSH Society Workshop


Leiden, the Netherlands - October 16, 2014

Facio Therapies will attend the 2014 FSH Society International Research Consortium Workshop, which will be held on October 17-18, 2014, prior to the opening of the American Society for Human Genetics (ASHG) Meeting in San Diego, California USA.  This meeting is the primary annual platform for clinicians, medical researchers and basic scientists to present and discuss… read more